<SEC-DOCUMENT>0001144204-19-033248.txt : 20190701
<SEC-HEADER>0001144204-19-033248.hdr.sgml : 20190701
<ACCEPTANCE-DATETIME>20190701083040
ACCESSION NUMBER:		0001144204-19-033248
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190628
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190701
DATE AS OF CHANGE:		20190701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IDEXX LABORATORIES INC /DE
		CENTRAL INDEX KEY:			0000874716
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010393723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19271
		FILM NUMBER:		19931345

	BUSINESS ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041
		BUSINESS PHONE:		2075560300

	MAIL ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDEXX CORP / DE
		DATE OF NAME CHANGE:	19600201
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv524627_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>UNITED STATES</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 10%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CURRENT REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date
of earliest event reported): <B>June 28, 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="logo_img1.gif" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 18pt Times New Roman, Times, Serif"><B>IDEXX LABORATORIES, INC.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>(Exact name of registrant as specified in its charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-right: -36.5pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 34%; padding-right: -58.2pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-19271</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: -5.3pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>01-0393723</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State or other jurisdiction</I></FONT></TD>
    <TD STYLE="padding-right: -58.2pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Commission File Number)</I></FONT></TD>
    <TD STYLE="padding-right: -5.3pt; padding-left: 5.4pt; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(IRS Employer Identification No.)</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>of incorporation)</I></FONT></TD>
    <TD STYLE="padding-right: -5.3pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: -5.3pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: -5.3pt; padding-left: 5.4pt; font-weight: bold; text-align: center; font-size: 10pt; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">One IDEXX Drive, Westbrook, Maine</FONT></TD>
    <TD STYLE="width: 50%; padding-right: -5.3pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>04092</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -5.3pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address of principal executive offices)</I></FONT></TD>
    <TD STYLE="padding-right: -5.3pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(ZIP Code)</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>207.556.0300</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>(Registrant's telephone number, including area code)</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Not Applicable</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>(Former name or former address, if changed since last report)</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<U>see</U> General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%; padding-right: -36.5pt; padding-left: 5.4pt; text-align: center; font-size: 10pt; layout-grid-mode: line"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><B><FONT STYLE="font-family: Wingdings">&#168;</FONT></B></FONT></TD>
    <TD STYLE="width: 89%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; text-align: center; font-size: 10pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><B><FONT STYLE="font-family: Wingdings">&#168;</FONT></B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><B><FONT STYLE="font-family: Wingdings">&#168;</FONT></B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -36.5pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><B><FONT STYLE="font-family: Wingdings">&#168;</FONT></B></FONT></TD>
    <TD STYLE="padding-right: -5.3pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities registered pursuant to Section&nbsp;12(b)
of the Act:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Title of each class</U></B></FONT></TD>
    <TD STYLE="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Trading Symbol(s)</U></B></FONT></TD>
    <TD STYLE="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Name of each exchange on which registered</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, $0.10 par value per share</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IDXX</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ Global Select Market</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of
1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). Emerging
growth company </FONT><FONT STYLE="font-family: Wingdings"><B><FONT STYLE="font-family: Wingdings">&#168;</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </FONT><FONT STYLE="font-family: Wingdings"><B><FONT STYLE="font-family: Wingdings">&#168;</FONT></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 5.02</TD><TD>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 1, 2019, IDEXX
Laboratories, Inc. (the &ldquo;Company&rdquo;) announced that Jonathan W. Ayers, the Company&rsquo;s Chairman of the Board, President
and Chief Executive Officer, is taking a medical leave of absence following a serious bicycling accident that occurred on June
27, 2019. In connection with Mr. Ayers&rsquo;s leave of absence, the Company&rsquo;s Board of Directors appointed Jay Mazelsky,
58, as the Company&rsquo;s Interim President and Chief Executive Officer, effective June&nbsp;28,&nbsp;2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A copy of the Company&rsquo;s
press release announcing these matters and containing certain biographical information concerning Mr. Mazelsky is attached hereto
as Exhibit 99.1 and incorporated herein by this reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><U>Exhibit No.</U></TD><TD STYLE="text-align: justify"><U>Description of Exhibit</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><A HREF="tv524627_ex99-1.htm">99.1</A></TD><TD STYLE="text-align: justify"><A HREF="tv524627_ex99-1.htm">Press Release entitled &ldquo;IDEXX Laboratories Chairman, President and Chief Executive Officer,
Jonathan Ayers, Taking Medical Leave of Absence,&rdquo; issued by the Company on July 1, 2019.</A></TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IDEXX LABORATORIES, INC.</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 0; font-weight: normal; text-align: left; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    July 1, 2019</FONT></TD>
    <TD STYLE="width: 3%; padding: 0; font-weight: normal; text-align: left; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid; padding: 0; font-weight: normal; text-align: left; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Sharon E. Underberg</FONT></TD>
    <TD STYLE="width: 10%; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><P STYLE="margin: 0pt 0"><FONT STYLE="font-size: 10pt">Sharon
                                         E. Underberg</FONT></P>


</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; layout-grid-mode: line; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Corporate Vice President,
        General Counsel and Secretary<BR>
&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv524627_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head><META content="text/html; charset=utf-8"></META></head><body style="font-size:10pt;font-family:Arial;color:black;"><div style="width:100%;margin-left:0pt">
<P STYLE="text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="text-align: center"><b>IDEXX Laboratories Chairman, President and Chief Executive Officer, Jonathan Ayers, Taking Medical Leave of Absence</b></p>
<br /><br />Jay Mazelsky, Executive Vice President, Companion Animal Group, Appointed Interim President and Chief Executive Officer</div><div style="width:100%;margin-left:0pt;"><div style="margin:0;margin-top:16pt;"><p>WESTBROOK, Maine, July 1, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Chairman, President and Chief Executive Officer, Jonathan Ayers, is on a medical leave of absence following a serious bicycling accident that occurred on June 27, 2019. </p><p>Effective June 28, 2019, the IDEXX Board of Directors has appointed Jay Mazelsky as Interim President and Chief Executive Officer. Mr. Mazelsky will assume Mr. Ayers&#39;s day-to-day management responsibilities and work closely with Brian McKeon, Chief Financial Officer, who will continue
to be responsible for the Company&#39;s finances and investor relations. Larry Kingsley, independent Lead Director of the IDEXX Board, will provide additional support to Jay, Brian and the management team.</p><p>&#34;First and foremost, we support Jon and his family and wish him a speedy and full recovery,&#34; said Mr. Kingsley, Lead Director of the IDEXX Board. &#34;Jon is a passionate, dedicated and well-respected leader of IDEXX. Jon has expressed his confidence in Jay, Brian and IDEXX&#39;s talented leadership team to continue to advance the Company&#39;s Purpose to enhance the health and well-being of pets, people, and livestock. IDEXX is well-positioned for the future, and the Board is confident that IDEXX&#39;s extremely capable executives and employees will continue successfully executing the Company&#39;s strategy and creating value for shareholders.&#34;</p><p><b>About Jay
Mazelsky</b></p><p>Prior to his appointment as Interim President and Chief Executive Officer of IDEXX, Mr. Mazelsky, 58, has been an Executive Vice President since joining IDEXX in August 2012. In addition to his day-to-day management responsibilities as Interim President and Chief Executive Officer, he oversees the Company&#39;s North American Companion Animal Group Commercial Organization and key elements of the innovation portfolio, including IDEXX&#39;s global in-house diagnostics and Veterinary Software and Service&#39;s businesses. From 2007 to 2012, Mr. Mazelsky was a Senior Vice President and General Manager of a number of businesses at Philips Healthcare. </p><p><b>About Brian McKeon</b></p><p>Mr. McKeon, 57, has been Executive Vice President, Chief Financial Officer, and Treasurer since January 2014. He leads IDEXX&#39;s finance, corporate development and strategy and
worldwide operations functions. Mr. McKeon served as a Director of IDEXX from July 2003 through December 2013, including serving as Chair of the Audit Committee and as a member of the Compensation Committee.</p><p><b>About IDEXX Laboratories</b></p><p>IDEXX Laboratories, Inc.  is a member of the S&amp;P 500<sup>&#174;</sup> Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people
and offers products to customers in over 175 countries. For more information about IDEXX and additional background on Mr. Mazelsky and Mr. McKeon, visit: www.idexx.com. </p><p><b>Note Regarding Forward-Looking Statements </b></p><p><i>This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. </i><i>Forward-looking statements can be identified by the use of words such as &#34;expects,&#34; &#34;may,&#34; &#34;anticipates,&#34; &#34;intends,&#34; &#34;would,&#34; &#34;will,&#34; &#34;plans,&#34; &#34;believes,&#34; &#34;estimates,&#34; &#34;should,&#34; &#34;project,&#34; and similar words and expressions. These forward-looking statements are intended to provide our current expectation or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not
guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review IDEXX&#39;s filings with the United States Securities and Exchange Commission (which are available
from the SEC&#39;s EDGAR database at www.sec.gov and via IDEXX&#39;s website at </i>www.idexx.com<i>).</i></p><p>Contact: </p><p><b>Investor Relations:
<br /></b>John Ravis
<br />1-207-556-8155
<br />john-ravis@idexx.com </p>
<br /><br /></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo_img1.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo_img1.gif
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M #/,,S/,9C/,F3/,S#/,_S/_ #/_,S/_9C/_F3/_S#/__V8  &8 ,V8 9F8
MF68 S&8 _V8S &8S,V8S9F8SF68SS&8S_V9F &9F,V9F9F9FF69FS&9F_V:9
M &:9,V:99F:9F6:9S&:9_V;, &;,,V;,9F;,F6;,S&;,_V;_ &;_,V;_9F;_
MF6;_S&;__YD  )D ,YD 9ID F9D S)D _YDS )DS,YDS9IDSF9DSS)DS_YEF
M )EF,YEF9IEFF9EFS)EF_YF9 )F9,YF99IF9F9F9S)F9_YG, )G,,YG,9IG,
MF9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PS
M ,PS,\PS9LPSF<PSS,PS_\QF ,QF,\QF9LQFF<QFS,QF_\R9 ,R9,\R99LR9
MF<R9S,R9_\S, ,S,,\S,9LS,F<S,S,S,_\S_ ,S_,\S_9LS_F<S_S,S___\
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$! 0 .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
